• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄连活性成分在人肝微粒体中的代谢相互作用。

Metabolic Interaction of the Active Constituents of Coptis chinensis in Human Liver Microsomes.

作者信息

Liu Songcan, Zhang Xinfeng, Qiu Furong, Miao Ping, Shen Shujiao, Zhu Leilei, Zeng Jin, Jiang Jian

机构信息

Department of Clinical Pharmacology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

出版信息

Evid Based Complement Alternat Med. 2015;2015:802903. doi: 10.1155/2015/802903. Epub 2015 Jan 6.

DOI:10.1155/2015/802903
PMID:25632291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4302345/
Abstract

Coptis chinensis is commonly used in traditional Chinese medicine. The study investigated metabolic interaction of the active constituents (berberine, coptisine, palmatine, and jatrorrhizine) of Coptis chinensis in human liver microsomes. After incubation of the four constituents of Coptis chinensis in HLMs, the metabolism of the four constituents was observed by HPLC. The in vitro inhibition experiment between the active constituents was conducted, and IC50 value was estimated. Coptisine exhibited inhibitions against the formation of the two metabolites of berberine with IC50 values of 6.5 and 8.3 μM, respectively. Palmatine and jatrorrhizine showed the weaker inhibitory effect on the formation of the metabolites of berberine. Berberine showed a weak inhibitory effect on the production of coptisine metabolite with an IC50 value of 115 μM, and palmatine and jatrorrhizine had little inhibitory effect on the formation of coptisine metabolite. Berberine, coptisine, and jatrorrhizine showed no inhibitory effect on the generation of palmatine metabolite (IC50 > 200 μM). The findings suggested that there are different degrees of metabolic interaction between the four components. Coptisine showed the strongest inhibition toward berberine metabolism.

摘要

黄连常用于传统中药。该研究调查了黄连活性成分(小檗碱、黄连碱、巴马汀和药根碱)在人肝微粒体中的代谢相互作用。在人肝微粒体中孵育黄连的四种成分后,通过高效液相色谱法观察这四种成分的代谢情况。进行了活性成分之间的体外抑制实验,并估算了半数抑制浓度(IC50)值。黄连碱对小檗碱的两种代谢产物的形成表现出抑制作用,IC50值分别为6.5和8.3 μM。巴马汀和药根碱对小檗碱代谢产物的形成表现出较弱的抑制作用。小檗碱对黄连碱代谢产物的产生表现出较弱的抑制作用,IC50值为115 μM,而巴马汀和药根碱对黄连碱代谢产物的形成几乎没有抑制作用。小檗碱、黄连碱和药根碱对巴马汀代谢产物的生成没有抑制作用(IC50>200 μM)。研究结果表明,这四种成分之间存在不同程度的代谢相互作用。黄连碱对小檗碱代谢的抑制作用最强。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c9/4302345/cf4fb8e5fc42/ECAM2015-802903.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c9/4302345/cf4fb8e5fc42/ECAM2015-802903.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84c9/4302345/cf4fb8e5fc42/ECAM2015-802903.001.jpg

相似文献

1
Metabolic Interaction of the Active Constituents of Coptis chinensis in Human Liver Microsomes.黄连活性成分在人肝微粒体中的代谢相互作用。
Evid Based Complement Alternat Med. 2015;2015:802903. doi: 10.1155/2015/802903. Epub 2015 Jan 6.
2
Isoquinoline Alkaloids from Franch: Focus on Coptisine as a Potential Therapeutic Candidate against Gastric Cancer Cells.黄连中的异喹啉生物碱:以小檗碱为靶点治疗胃癌细胞。
Int J Mol Sci. 2022 Sep 7;23(18):10330. doi: 10.3390/ijms231810330.
3
[Metabolism, transformation and distribution of Coptis chinensis total alkaloids in rat].[黄连总生物碱在大鼠体内的代谢、转化及分布]
Zhongguo Zhong Yao Za Zhi. 2010 Aug;35(15):2017-20. doi: 10.4268/cjcmm20101523.
4
Cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and their major constituents (berberine, coptisine and icariin) on hepatoma and leukaemia cell growth.黄连和淫羊藿提取物及其主要成分(小檗碱、黄连碱和淫羊藿苷)对肝癌和白血病细胞生长的细胞毒性作用。
Clin Exp Pharmacol Physiol. 2004 Jan-Feb;31(1-2):65-9. doi: 10.1111/j.1440-1681.2004.03951.x.
5
Study on the mechanism of Coptis chinensis Franch. And its main active components in treating Alzheimer's disease based on SCFAs using Orbitrap Fusion Lumos Tribrid MS.基于短链脂肪酸运用轨道阱融合 Lumos 三合一质谱研究黄连及其主要活性成分治疗阿尔茨海默病的机制
J Ethnopharmacol. 2023 Jul 15;311:116392. doi: 10.1016/j.jep.2023.116392. Epub 2023 Apr 5.
6
[Establishment of the control substance of plant drug and fingerprints of Coptis chinensis].[植物药对照品的建立及黄连指纹图谱研究]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Dec;26(6):622-7.
7
[In vitro and In vivo effects of six Coptidis alkaloids on liver microsomes UGTs and UGT1A1 activities in rats and mice].六种黄连生物碱对大鼠和小鼠肝脏微粒体UGTs及UGT1A1活性的体内外作用
Zhongguo Zhong Yao Za Zhi. 2016 Jan;41(2):309-313. doi: 10.4268/cjcmm20160223.
8
Protective Effects of Coptis chinensis Rhizome Extract and Its Constituents (Berberine, Coptisine, and Palmatine) against α-Synuclein Neurotoxicity in Dopaminergic SH-SY5Y Cells.黄连根茎提取物及其成分(小檗碱、黄连碱和巴马汀)对多巴胺能 SH-SY5Y 细胞中α-突触核蛋白神经毒性的保护作用。
Biol Pharm Bull. 2024;47(4):827-839. doi: 10.1248/bpb.b23-00758.
9
[Microcalorimetric investigation on the interaction of six alkaloids from rhizoma coptidis].[黄连中六种生物碱相互作用的微量量热法研究]
Yao Xue Xue Bao. 2013 Dec;48(12):1807-11.
10
Analysis of four alkaloids of Coptis chinensis in rat plasma by high performance liquid chromatography with electrochemical detection.高效液相色谱电化学检测法分析大鼠血浆中的四种黄连生物碱。
Anal Chim Acta. 2012 Aug 6;737:99-104. doi: 10.1016/j.aca.2012.05.054. Epub 2012 Jun 4.

引用本文的文献

1
Electrospinning Fabrication of Poly(vinyl alcohol)/ Extract Nanofibers for Antimicrobial Exploits.用于抗菌应用的聚乙烯醇/提取物纳米纤维的静电纺丝制备
Nanomaterials (Basel). 2018 Sep 17;8(9):734. doi: 10.3390/nano8090734.
2
Metabolism and Metabolic Inhibition of Xanthotoxol in Human Liver Microsomes.花椒毒素在人肝微粒体中的代谢及代谢抑制作用
Evid Based Complement Alternat Med. 2016;2016:5416509. doi: 10.1155/2016/5416509. Epub 2016 Mar 10.
3
Effect of Rhizoma coptidis (Huang Lian) on Treating Diabetes Mellitus.黄连对治疗糖尿病的作用。

本文引用的文献

1
Pharmacokinetics and metabolism of jatrorrhizine, a gastric prokinetic drug candidate.药代动力学和代谢研究:一种胃动力候选药物——建曲碱。
Biopharm Drug Dispos. 2012 Apr;33(3):135-45. doi: 10.1002/bdd.1779. Epub 2012 Mar 16.
2
CYP2D plays a major role in berberine metabolism in liver of mice and humans.细胞色素P450 2D(CYP2D)在小鼠和人类肝脏中黄连素代谢过程中起主要作用。
Xenobiotica. 2011 Nov;41(11):996-1005. doi: 10.3109/00498254.2011.597456. Epub 2011 Jul 25.
3
Clinically relevant genetic variations in drug metabolizing enzymes.
Evid Based Complement Alternat Med. 2015;2015:921416. doi: 10.1155/2015/921416. Epub 2015 Oct 5.
药物代谢酶中的临床相关遗传变异。
Curr Drug Metab. 2011 Jun;12(5):487-97. doi: 10.2174/138920011795495321.
4
In vitro inhibition of Huanglian [Rhizoma coptidis (L.)] and its six active alkaloids on six cytochrome P450 isoforms in human liver microsomes.黄连及其六种活性生物碱对人肝微粒体中六种细胞色素 P450 同工酶的体外抑制作用。
Phytother Res. 2011 Nov;25(11):1660-5. doi: 10.1002/ptr.3475. Epub 2011 Mar 21.
5
Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats.小檗碱在大鼠体内的血浆水平较低,这是由于其广泛的肠道首过消除和主要的肝脏分布所致。
Drug Metab Dispos. 2010 Oct;38(10):1779-84. doi: 10.1124/dmd.110.033936. Epub 2010 Jul 15.
6
Oxidative demethylenation and subsequent glucuronidation are the major metabolic pathways of berberine in rats.氧化脱甲基化和随后的葡萄糖醛酸化是小檗碱在大鼠体内的主要代谢途径。
J Pharm Sci. 2009 Nov;98(11):4391-401. doi: 10.1002/jps.21721.
7
LC/MS/MS for identification of in vivo and in vitro metabolites of jatrorrhizine.用于鉴定小檗碱体内和体外代谢产物的液相色谱-串联质谱法。
Biomed Chromatogr. 2008 Dec;22(12):1360-7. doi: 10.1002/bmc.1066.
8
Inhibitory effects of seven components of danshen extract on catalytic activity of cytochrome P450 enzyme in human liver microsomes.丹参提取物七种成分对人肝微粒体细胞色素P450酶催化活性的抑制作用。
Drug Metab Dispos. 2008 Jul;36(7):1308-14. doi: 10.1124/dmd.108.021030. Epub 2008 Apr 14.
9
Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine.天然植物生物碱黄连素治疗2型糖尿病和血脂异常
J Clin Endocrinol Metab. 2008 Jul;93(7):2559-65. doi: 10.1210/jc.2007-2404. Epub 2008 Apr 8.
10
Optimization of antibacterial activity by Gold-Thread (Coptidis Rhizoma Franch) against Streptococcus mutans using evolutionary operation-factorial design technique.采用进化操作-析因设计技术优化黄连对变形链球菌的抗菌活性
J Microbiol Biotechnol. 2007 Nov;17(11):1880-4.